Prescription drug copayment, A1C level, diabetic complications, cardiac events, inpatient admissions, and visits to primary care, endocrinology, cardiology, and the emergency department were evaluated as time-varying covariates.
Furthermore, plasma liraglutide concentrations from all trial visits will be evaluated as time-dependent differences in excursions and as total responses during the study period in both groups.
The fever duration period will be evaluated as time-to-event data and the median duration of the fever and its 95% CI will be estimated by the Kaplan-Meier method.
Prescription drug copayment, diabetic complications, and cardiac events were evaluated as time-varying covariates with diabetic complications and cardiac events treated as flags that turned on (and stayed on) as of the date of first occurrence.
Cellular proliferation was assessed by crystal violet staining and quantification by measuring the absorbance at 570 nm of control and treated cells at days 0, 3 and 6 p.t., and results expressed as percentage of proliferation (during standardization) or in a proliferative curve (evaluated as times as compared with day 0).
And to continue to evaluate as time passes.
We also found aspects of timing (duration of morning stiffness, six weeks symptom duration) sometimes problematic to evaluate, as time perceptions are different compared to the Western world.
Dynamic troponin changes over time were evaluated as well.
Colonic transit time was evaluated as the time interval between dye injection and the discharge of the first blue pellet.
The design objective is set to maximize the energy flux at the specified wave absorbing area during some time period so that the objective function is evaluated as the time integration of a Poynting vector formulation.
